Posts

Showing posts matching the search for Morningstar

Vanguard's Mega Cap MGK vs Invesco's Small-Cap RZG: A Long-Term Growth ETF Showdown

Image
Vanguard's Mega Cap MGK vs Invesco's Small-Cap RZG: A Long-Term Growth ETF Showdown THE MONEYWISE JOURNAL  ·  finance  ·  Saturday, August 08, 2026 Launched in 2007 and 2006 respectively, these two growth ETFs have distinct approaches to capturing market returns. By MoneyWise Guide The Vanguard Morningstar Mega Cap Growth ETF (MGK) and Invesco S&P SmallCap 600 Revenue ETF (RZG) have been vying for investors' attention in the U.S. market. Launched in 2007 and 2006 respectively, these two growth ETFs have distinct approaches to capturing market returns. While MGK focuses on the largest companies in the market, RZG targets smaller companies with strong revenue growth. Key Takeaways MGK has a lower expense ratio of 0.05% compared to RZG's 0.35%. RZG has a higher dividend yield of 0.4% compared to MGK's 0.3%. MGK has a larger weighting of Nvidia at 13.24% compared to RZG's 0.3%. MGK has a larger number of stock...

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

Image
As a savvy investor, you're likely always on the lookout for the next big thing in the stock market. But sometimes, the best investments are the ones that fly under the radar. In this article, we'll explore the world of healthcare investing and pit two popular options against each other: the iShares Nasdaq Biotechnology ETF (IBB) and the Vanguard Healthcare ETF (VHT). What's the Difference Between XLV and PBE? The iShares Nasdaq Biotechnology ETF (PBE) and the Vanguard Healthcare ETF (XLV) are both popular options for investors looking to tap into the healthcare sector. But while they may seem similar at first glance, they have some key differences. PBE is a focused biotech specialist, meaning it's heavily weighted in companies that develop and market new treatments and medications. XLV, on the other hand, is a low-cost healthcare ETF that takes a diversified approach, investing in a wide range of healthcare companies, from pharmaceuticals to healthcare providers. ...